Getting Started with Quadramet®
| Oncologist | Office Staff | |
|---|---|---|
| 1. Oncologist writes the referral | 2. If insurance verification or precertification assistance is required, please call the reimbursement support hotline at 888-900-2674 3. Obtains CBC with platelets if not done recently |
|
| 4. Benefits verification* | ||
| 5. Schedules Quadramet injection at a facility licensed to administer Samarium-153 6. Notifies patient of date and time† 7. Schedules a 2-week follow-up with patient 8. Reviews Quadramet information with patient, including radiation safety, possible flare reaction, pain management and follow-up schedule |
||
| 9. Injection by a Nuclear Medicine physician or Radiation Oncologist licensed to administer radiopharmaceuticals | ||
| 10. Follow-up visit with oncologist | 11. Blood work done 12. Blood counts should be monitored weekly for at least 8 weeks, or until recovery of adequate bone marrow function |
*Patient may be eligible for the EUSA Pharma Community Access Patient Program (CAPP) if s/he has no insurance.
†Quadramet is administered on Wednesdays, Thursdays and Fridays.
REFERENCES:
- Serafini AN, Houston SJ, Resche I, et al. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol. 1998;16:1574-1581.
